Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.
Nutritional status, body surface and low body mass/body mass index are related to dosing - reduction and severe gastrointestinal toxicity induced by Afatinib in patients with non-small cell lung cancer.